Chylomicronemia

National Lipid Association Releases Expert Clinical Review on Familial Chylomicronemia Syndrome (FCS)

The National Lipid Association (NLA) has released a comprehensive clinical review titled “Familial Chylomicronemia Syndrome: An Expert Clinical Review from…

National Lipid Association and American Society for Preventive Cardiology Release Joint Expert Consensus on Chylomicronemia Management

The National Lipid Association (NLA), in collaboration with the American Society for Preventive Cardiology (ASPC), has released a Joint Expert…

Ionis Receives FDA Approval for TRYNGOLZA (Olezarsen) for Adults with FCS

On December 19, 2024, Ionis Pharmaceuticals, Inc. received FDA approval for TRYNGOLZA (Olezarsen) as an adjunct to diet to reduce triglycerides…

Industry Innovations | Episode 7: A New Era for FCS: Diagnosis, Daily Life & the Science That’s Changing Everything

Familial chylomicronemia syndrome (FCS) is one of the rarest and most challenging lipid disorders to manage, but the landscape is…

The Lipid Panel – Chylomicronemia

North American Familial Chylomicronemia Syndrome (NAFCS) Scoring Tools

North American Familial Chylomicronemia Syndrome (NAFCS) Scoring Tools

Recognition and Management of Persistent Chylomicronemia

S5E2: Palisade Phase 3 Data

Alan Brown, MD, FACC, MNLA talks with Robert A. Hegele MD, FRCP about the Palisade Phase 3 Data.

S6E2: From Research to Reality: Advancing FCS Therapy

Listen to Dr. Jones speak with Shannon Christen about FCS research and therapies and recent developments.

S6E4: Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association

Listen to Dr. Alan Brown discuss the latest FCS paper with Dr. Fiza Javed and Dr. Nivedita Patni.

S6E5: Recognition and Management of Persistent Chylomicronemia

Dive into the complexities of Persistent Chylomicronemia with this special episode recorded live at the recent National Lipid Association Scientific…

Recognition and Management of Persistent Chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology

Patients with persistent chylomicronemia and alarm features have a very high risk of acute pancreatitis, similar to FCS.

Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association

Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder characterized by extreme hypertriglyceridemia and a high risk of recurrent…